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bjectives This study sought to assess the safety and the effectiveness of endovascular stent graft-
ng of chronic aortic dissection (AD) in Marfan patients.
ackground The management of chronic AD of the descending thoracic aorta (DTA) is challenging.
his is especially true in Marfan patients, who tend to exhibit poor short- and long-term results after
onventional surgery.
ethods Fifteen patients with Marfan’s syndrome and chronic AD of the DTA were identiﬁed
mong the 457 patients of the European Talent Registry. All patients underwent endovascular treat-
ent.
esults No major adverse event was encountered during the procedure. Five patients experienced
primary endoleak (type 1, n  4; type 2, n  1). Three of them died, and 1 underwent successful
onversion to open surgery. Five other patients experienced secondary endoleak (type 1, n  4;
ype 3, n  1). Four of them underwent successful conversion to either open or endovascular rein-
ervention. Two other patients underwent successful conversion to open repair because of second-
ry aortic enlargement below the stent graft. After a mean follow-up of 2.1  1.4 years, 12 patients
re alive. Of these 12, conversion to open repair was successfully performed in 5 patients. In the
emaining 7 patients, complete thrombosis of the false lumen was achieved in 6 patients, with par-
ial thrombosis in 1 patient.
onclusions Endovascular stent grafting of the dissected DTA is feasible in selected Marfan patients
ith low mortality and morbidity rates. Nevertheless, the rate of primary and secondary endoleak is
igh. Close imaging surveillance is crucial to detect secondary aortic complications and to assess
ong-term results. (J Am Coll Cardiol Intv 2008;1:673–80) © 2008 by the American College of
ardiology Foundation
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674he aim of this work was to assess the safety and the
ffectiveness of thoracic aortic endovascular stent grafting in
arfan patients. Fifteen patients with chronic aortic dis-
ection (AD) underwent endovascular treatment. After a
ean follow-up of 2.1  1.4 years, 12 patients are alive.
ive of these underwent successful conversion to open
epair. In the remaining 7 patients, complete thrombosis of
he false lumen was achieved in 6 patients and partial
hrombosis in 1 patient. Endovascular stent grafting of the
issected descending thoracic aorta (DTA) is feasible in
arfan patients with low mortality and morbidity rates.
evertheless, the rate of primary and secondary endoleak is
igh.
Marfan’s syndrome is an autosomal dominant pathology
f the connective tissues caused by mutations of the fibrillin
ene located in chromosome 15q. Mutant fibrillin is syn-
hesized with the inability to bind calcium and weakening of
he elastic layers of connective tissue (1). In Marfan pa-
ients, aortic disease is characterized by progressive dilata-
ion of the aortic root and annulus, aortic valve incompe-
ence, and increased risk of proximal AD or rupture (1–3).
Unlike aortic root surgery in Marfan patients, which is
well codified and may be rou-
tinely performed electively or
emergently, the management of
the dissected DTA is still chal-
lenging (4). In cases of uncom-
plicated AD of the DTA, med-
ical treatment remains the best
therapeutic option. However,
aneurysmal dilatation of the de-
scending aorta is a frequent crit-
cal late complication responsible for poor long-term out-
omes (1,2). To prevent aortic rupture, lifelong close clinical
nd imaging follow-up is essential to determine the best
iming for intervention (5–8).
Endovascular stent grafting has recently been reported as
safe and effective therapeutic option for patients with
issection of the DTA, with favorable results when com-
ared with conventional open surgery results. This is espe-
ially true in the case of chronic AD (8,9). Stent grafting in
arfan patients has been reported in small series or case
eports, providing controversial results (10–12). The aim of
his study was to assess the mid-term results of aortic stent
rafting in patients with Marfan’s syndrome. Patients were
etrospectively pulled from the cohort of 457 patients who
nderwent stent graft repair in 7 European centers.
ethods
opulation. The entire cohort study consisted of 457 con-
ecutive patients who underwent endovascular thoracic aor-
ic repair with the Talent Thoracic Stent Graft (Medtronic,
bbreviations
nd Acronyms
D  aortic dissection
SA  American Association
f Anesthesiologists
TA  descending thoracic
ortainneapolis, Minnesota). Seven European referral centers cBologna, Italy; Toulouse, Lille, and Marseille, France;
ostock, Germany; Vienna, Austria; Nieuwegein, the
etherlands) provided data from patients consecutively
reated with the Talent Thoracic Stent Graft between
ovember 1996 and March 2004 (13). The ethical com-
ittee of each institute approved the study. Data were
rospectively collected on case report forms and entered in
atabases. Case report forms were all reviewed and checked
or inconsistencies. In cases of discrepancies, the participat-
ng investigator at each site was asked to ensure appropriate
nterpretations of events.
atient characteristics and imaging evaluation. Of the entire
ohort, patients with Marfan’s syndrome and chronic dis-
ection of the DTA were retrospectively extracted for this
tudy. All the patients presented with an aneurismal dilata-
ion of the DTA (defined as a diameter over 40 mm and
apid aortic enlargement of more than 0.5 cm within a
eriod of 6 months). These patients were considered high
isk, thus favoring intervention. All were treated with stent
rafts.
Before treatment, all patients were examined by com-
uted tomography or magnetic resonance imaging, in ad-
ition to angiography or transesophageal echocardiography
Fig. 1). Morphological data on maximum aortic diameter,
roximal and distal anatomic extension of the lesion, and
istance from the entry of the AD to the ostium of the left
ubclavian artery were recorded. Information on the
rocedure (number of stent grafts used, aortic covered
ength, and immediate angiographic results) was also
ecorded.
Follow-up analysis was performed on clinical and imag-
ng findings until the last visit date and included all adverse
vents. Clinical and imaging follow-up was performed in
ach center according to accepted guidelines. Follow-up
onsisted of a standard chest X-ray and contrast-enhanced
piral-computed tomography or magnetic resonance imag-
ng before discharge and at 3, 6, and 12 months after the
ntervention. The same imaging, as well as clinical follow-
p, was performed annually thereafter. In case of rapid
ortic enlargement of more than 0.3 cm within a 1-year
eriod, subsequent imaging and clinical follow-up was
erformed at 3-month intervals.
evice description and endovascular procedures. The endo-
ascular Talent device was used as previously described (13).
tent grafts were 5% to 10% oversized in comparison to the
iameter of the normal aorta and were at least 30 to 40 mm
onger than the lesion.
tatistical analysis. Incidence rates of events are reported
y the number of patients experiencing the event, fol-
owed by the corresponding percentage. Continuous data
re reported by giving the mean  SD and/or median
minimal and maximal values). Several factors were
pecifically analyzed: age, gender, pre-operative Ameri-
an Association of Anesthesiologists (ASA) score, history
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675f aortic root surgery, maximal aortic diameter, extension
f the AD below the diaphragm, number of deployed
tent grafts, coverage of the left subclavian artery, emer-
ency setting, and covered aortic length. These factors
ere analyzed to assess their potential influence on
utcomes, including endoleak, reintervention (endovas-
ular or open), conversion to open surgery, and death.
he bilateral Fisher exact test was used to assess quali-
ative variables, and the nonparametric Wilcoxon test was
sed to assess quantitative variables. Statistical analyses were
arried out with SAS software, version 9.1 (SAS Institute,
Figure 1. Imaging of Chronic Aortic Dissection of the Descending Thoracic
(A to D) Spiral computed tomography shows a chronic aortic dissection of the
ative angiographic images show the proximal edge of the device distal to the
lumen. (H) Magnetic resonance imaging demonstrates the exclusion of the fal
strates the exclusion of the entry tear and the false lumen 2 years after the prary, North Carolina). wesults
rom November 1996 through March 2004, 15 patients
11 males) with Marfan’s syndrome were identified as
art of the European Multicenter Talent Thoracic Reg-
stry.
re-operative data. All the patients presented with a
hronic dissection of the DTA. Two patients were
reated urgently because of an impending rupture of the
issected DTA (hemodynamically stable). The remaining
3 patients presented with a progressive dilatation and
ending thoracic aorta in a patient with Marfan’s syndrome. (E to G) Perioper-
rotid artery ostium, with complete exclusion of the entry tear and the false
en 1 year after the procedure. (I to K) Spiral computed tomography demon-
re.Aorta
desc
left ca
se lumere treated electively (Table 1).
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676Mean age was 40 12 years (range 22 to 61 years). Mean
SA score was 2.9  0.2. The main comorbidities were
ypertension (n 7), chronic pulmonary obstructive disease
n  6), chronic renal failure (n  5), and diabetes mellitus
n  1).
Eleven patients had previously undergone aortic root
urgery (Bentall procedure: n  9; Tyrone-David proce-
ure: n  2). For those patients, the mean time between
urgery of the ascending aorta and stent grafting of the
TA was 5.7  2.9 years (range 1.5 to 10.7 years).
The pre-operative morphologic assessment showed a
ean aortic diameter of 61.3  24.7 mm. The 2 patients
Table 1. Pre-operative Characteristics of the Patients
Patients
Age mean  SD, yrs 38.7  12.8
Male/female ratio 9:3
Pre-operative ASA score, mean  SD 2.9  2.5
Comorbidities, n
Diabetes 1
Hypertension 7
Chronic renal failure 5
Chronic obstructive pulmonary disease 6
Aortic disease, n
Chronic aortic dissection of the thoracic
descending aorta
12
Progressive aortic enlargement 13
Impending rupture 2
Mean aortic diameter, mm 57.5  26.8
Past history of surgery of the aortic root, n
Bentall 9
Aortic valve sparing surgery 2
ASA American Association of Anesthesiologists; SD standard deviation.Figure 2. Flow Chart of Perioperative Outcomesith impending aortic rupture had respective aortic diam-
ters of 33 and 46 mm. Mean pre-operative aortic diameter
f the other 13 patients was 64.6  25.7 mm.
The mean distance between the entry tear and the ostium
f the left subclavian artery was 47.7 30.8 mm (range 0 to
00 mm). The AD was limited to the DTA in only 2
atients, and the dissection extended below the diaphragm
n the remaining 12 patients. One patient had involvement
f the aortic arch and the DTA.
erioperative data. Transfemoral stent graft deployment
as uneventful and technically successful in all the patients.
n average of 1.5  0.7 stent grafts was used (range 1 to 3
tent grafts). The ostium of the left subclavian artery had to
e covered in 2 patients. No deaths occurred, and no
onversion to open surgical intervention was required dur-
ng the procedures. No patient sustained paraplegia, and 1
atient presented with a transient hemispheric stroke. The
ean duration of hospital stay was 14.4  13 days (Fig. 2).
Post-deployment angiography demonstrated the exclu-
ion of the false aneurysms without endoleak in 10 patients.
Primary endoleaks were seen in 5 patients (type 1, n  4;
ype 2, n  1). Two patients with type 1 primary endoleaks
ied of rupture of the descending aorta (n  1, post-
perative day 274) or of the abdominal aorta (n  1,
ost-operative day 335) before reintervention. Another
atient with a type 1 primary endoleak died after endovas-
ular reintervention (n  1, 2.8 years after the initial
rocedure). One patient with a type 1 primary endoleak
nderwent successful secondary conversion to open surgery
n  1, 1 month after the endovascular procedure). The
rimary type 2 endoleak (from an intercostal artery) spon-
aneously healed.
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677id-term post-operative data. Five other patients presented
ith secondary endoleaks (type 1, n  4; type 3, n  1).
wo patients with secondary type 1 endoleaks underwent
uccessful secondary conversion to open repair (n  2, 3.7
nd 5.2 years after the endovascular procedure). One patient
ith a secondary type 1 endoleak underwent successful
ndovascular reintervention (n  1, 1 month after the
ndovascular procedure). One mild secondary type 1 en-
oleak was observed with partial thrombosis of the false
umen. The patient with a secondary type 3 endoleak
nderwent successful secondary endovascular reintervention
n  1, post-operative month 9). Two other patients
resented with secondary aortic enlargement below the
tent graft because of a persistent celiac entry. Both
nderwent successful conversion to open thoracic aortic
eplacement (n  2, 0.2 and 3.1 years after the endovas-
ular procedure) (Fig. 3).
Table 2 presents the peri- and post-operative patient
haracteristics and outcomes. Patients with primary en-
oleaks had significantly longer covered aortic segments
p  0.05). Also, large aortic diameter was found to be a
orderline predictive factor for reintervention (p  0.06).
he other statistical tests did not achieve significance.
Follow-up (before discharge; at 3, 6, and 12 months; and
very subsequent year) was performed in all the patients.
fter the first yearly visit, the imaging and clinical follow-up
eriods for 2 patients were reduced to 3-month intervals
ecause of rapid enlargement of the dissected DTA (be-
ween 0.3 and 0.5 mm over 12 months). Overall, mean time
nterval between the last visit and the outcome event was 1.7
Figure 3. Flow Chart of Mid-Term Postoperative Outcomes1 months. oMean follow-up for the cohort was 2.1 1.4 years (range
.8 to 4.9 years). Twelve patients are still alive. Conversion
o open repair was required and was successful in 5 patients.
n the remaining 7 patients, complete thrombosis of the
alse lumen was achieved in 6 patients and partial throm-
osis with stable aortic diameter was achieved in 1 patient.
In summary, for the cohort of 15 patients, 7 are alive with
artial or complete false lumen thrombosis, 5 are alive after
conversion to open surgery, and 3 are dead.
Seven living patients underwent a secondary procedure
open or endovascular).
iscussion
n patients with Marfan’s syndrome, AD with rupture has
ong been the main cause of death, even in younger patients.
odern surgical techniques of ascending aortic repair have
een essential for improving patient prognoses. Bentall
rocedures or aortic root reconstruction are currently elec-
ively performed with acceptable morbidity and mortality
ates.
Unlike in aortic root surgery, which is well codified and
ay be routinely performed on patients with Marfan’s
yndrome, management of the dissected DTA is still chal-
enging. This is especially true in cases involving aneurysmal
ilatation (1,4,14). In contrast with the excellent surgical
esults of elective root replacement, both early and long-
erm results of repeat surgery for the descending aorta
emain poor (15). De Olivera et al. (16) reported on 6
urgical repairs of the DTA after previous valve-sparing
perations. In this series, 3 patients died after surgical repair
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678f the descending aorta, 1 sustained post-operative paraple-
ia, and 2 survived to surgery without complication (16).
urther, Alexiou et al. (17) reported a mortality rate of 33%
n Marfan patients undergoing secondary surgery of the
TA. Gott et al. (18) reported 30.8% mortality among 26
atients subjected to a secondary surgical procedure for
rogressive disease or dissection. In a larger study focusing
n long-term data, 63 of 653 Marfan patients with previous
ortic root replacement required late surgery, and only 46
atients were still alive at the last follow-up (5).
Endovascular stent grafting has recently been reported
s a valuable alternative therapeutic option to conven-
ional open surgery for patients with dissection of the
TA (8,19,20). The results appear promising, especially
n comparison with the poor results of conventional open
urgery. This is also true in cases involving chronic AD
9,15). Nevertheless, the English literature concerning
tent grafting in Marfan patients is scarce (10 –12).
Our study represents the largest literature-reported
eries that assessed early and mid-term results of stent
rafting in Marfan patients, specifically those with an
neurysmal enlargement in the setting of a chronic
horacic descending AD.
This series demonstrates the technical feasibility of
tent graft repair in Marfan patients with chronic dissec-
ion of the DTA compared with patients with similar
Table 2. Peri- and Post-operative Characteristics of the Patients and Outco
Primary Endoleak Secondary Endoleak
Yes
(n  5)
No
(n  10)
Yes
(n  5)
No
(n  10)
Age, yrs* 35 [22–52] 43 [24–61] 44 [24–61] 33 [22–52]
Female, n (%) 1 (20) 3 (30) 1 (20) 3 (30)
ASA score* 3 [3–3] 3 [2–3] 3 [3–3] 3 [2–3]
Prior aortic root
surgery, n (%)
3 (60) 8 (80) 4 (80) 7 (70)
Aortic diameter,
mm*
46 [39–92] 56 [33–136] 55 [40–70] 56 [33–136]
Extension below the
diaphragm, n (%)
4 (80) 9 (90) 5 (100) 8 (80)
Number of stent
grafts 1, n (%)
4 (80) 1 (10) 0 (0) 5 (50)
Coverage of the left
subclavian artery,
n (%)
1 (20) 1 (10) 0 (0) 2 (20)
Emergency setting,
n (%)
1 (20) 1 (10) 0 (0) 2 (20)
Aortic length
covered, mm*‡
180 [150–200]§ 125 [60–200]§ 100 [60–134] 165 [130–200]
*Median (minimal andmaximal value);†p 0.06;‡data for aortic length coveredwere available for
caution because of the small number of patients. Only significant tests are shown in the table; othe
Abbreviation as in Table 1.horacic disease but without Marfan’s syndrome (13). The nndovascular devices were successfully deployed in all the
atients; no patient died perioperatively; there were no peri-
perative conversions to open repair; and limited complications
ere observed. In particular, no patients presented with para-
legia, demonstrating the ability of endovascular procedures to
reserve the integrity of the aorta.
Our series also points out the limitations of endovascular
rocedures in Marfan patients. The rate of primary en-
oleak (33%) was higher in Marfan patients than in patients
ithout Marfan’s syndrome (21.4%) (13). In longer covered
ortic segments, the potential risk for primary endoleak was
igher. In addition, large aortic diameter was a borderline
redictive factor for reintervention. Because of the limited
umber of patients included in this analysis, other statistical
ests were not significant. For the same reason, these results
hould be interpreted with caution, and definitive conclu-
ions regarding good or bad candidates for endovascular
epair may be premature. The high rate of primary and
econdary endoleaks may constitute a major problem in
hese patients. This higher rate is probably related to the
ragility of the tissues in Marfan’s syndrome. However, it is
mportant to consider that these cases were treated several
ears ago, at the beginning of the dissection endovascular
xperience, using a first-generation thoracic device. It is
ossible that more experience, improved imaging assess-
ent, and better device conformability could mitigate the
Reintervention Open Conversion Death
es
 4)
No
(n  11)
Yes
(n  5)
No
(n  10)
Yes
(n  3)
No
(n  12)
2–52] 32 [22–61] 32 [22–61] 43 [27–52] 35 [27–47] 43 [22–61]
5) 3 (27) 0 (0) 4 (40) 1 (33) 3 (25)
–3] 3 [2–3] 3 [3–3] 3 [2–3] 3 [3–3] 3 [2–3]
00) 7 (64) 4 (80) 9 (90) 2 (67) 9 (75)
8–92]† 54 [33–136]† 55 [40–60] 62 [33–136] 70 [39–92] 55 [33–136]
00) 9 (82) 5 (100) 8 (80) 3 (100) 10 (83)
5) 4 (36) 2 (40) 3 (30) 2 (67) 3 (25)
) 2 (18) 1 (20) 1 (10) 0 (0) 2 (17)
) 2 (18) 1 (20) 1 (10) 0 (0) 2 (17)
00–134] 135 [60–200] 130 [60–200] 134 [100–180] 150 [150–150] 132 [60–200]
nts; §p 0.05. Percentages are given to describe the population. These should be interpretedwith
sults did not achieve significance.mes
Y
(n
46 [2
1 (2
3 [3
4 (1
68 [5
4 (1
1 (2
0 (0
0 (0
117 [1
11 patie
r test reegative long-term outcomes of endovascular treatment.
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679hese primary endoleaks, especially primary type 1 en-
oleaks, appear to be more severe in Marfan patients,
ith 3 aortic-related deaths before reintervention (of 5
rimary endoleaks). The poor outcomes in cases of
rimary type 1 endoleaks underline the necessity for
uick and aggressive management of such endoleaks in
arfan patients. This also supports the necessity for
loser imaging and monitoring.
The secondary endoleaks were also more frequent in
arfan patients than in the non-Marfan’s population,
ith a 3-fold higher rate of such events (33% vs. 10.4%)
13). Secondary type 1 endoleaks were encountered in 4
atients. Two patients underwent successful conversion
o open repair because of aortic enlargement, and 2
econdary type I endoleaks spontaneously healed. No
ortic-related complications occurred in these patients
ith secondary type 1 endoleaks.
As in the non-Marfan’s population, another problem in
epair of AD of the DTA was encountered. Two patients
resented with aortic enlargement below the stent grafts
ithout evidence of endoleak. These aortic enlargements
ere due to the presence of a re-entry tear at the level of the
eliac artery. Both required secondary conversion to open
epair.
Despite these limitations of aortic endovascular treatment
n Marfan patients, 12 patients were alive after a mean
ollow-up of 2.1 1.4 years. Conversion to open repair was
equired and successful in 5 patients. Like the findings of
nce et al. (12), this point suggests that stent grafting could
e considered as a safe therapeutic option as a bridge to
urgery in case of acute aortic syndrome complicating a
hronic AD. All the secondary conversions to open repair
ere successfully performed, and the open procedure was
ot made more difficult by the presence of an intra-aortic
evice. In the remaining 7 patients, complete thrombosis of
he false lumen was achieved in 6 patients, and partial
hrombosis with stable aortic diameter was achieved in 1
atient. These encouraging outcomes in 7 patients highlight
he potential applicability of endovascular therapy in Marfan
atients, especially in emergency cases. Longer follow-up is
till mandatory to assess the effectiveness of aortic stent
rafting in such patients.
tudy limitations. This study has several limitations: 1) data
ere prospectively collected but retrospectively analyzed, 2)
he depth of the statistical analysis was limited because of
he relatively small number of patients included in this
tudy, 3) the comparison with conventional surgery is
imited, as results could only be compared with historical
tudies of open repair, and 4) this study only included
atients treated exclusively with the Medtronic Talent
horacic Stent Graft, and it is not possible to evaluate the
erformance of other devices in this cohort.onclusions
lthough the cohort size was limited, this study demon-
trates the feasibility of stent grafting in Marfan patients
ith chronic dissection of the DTA. Immediate outcomes
ere favorable, without increased perioperative mortality
ates. However, the rate of primary and secondary endoleaks
s high compared with the rate of endoleaks in patients who
o not have Marfan’s syndrome. This is probably due to the
ragility of the aortic tissues in Marfan patients. Closer
maging surveillance is crucial to detect secondary aortic
omplications to enable aggressive treatment of endoleaks.
tent grafting can also be considered a therapeutic option as
bridge to conventional open surgery in situations involving
cute aortic syndrome or expansion of the false lumen in
hronic AD.
eprint requests and correspondence: Dr. Hervé Rousseau,
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